Empirico

Empirico is a biotechnology company leveraging human genetics to transform therapeutic discovery. Empowered by foundational technology platforms, Empirico is focused on discovering and developing novel medicines designed to mimic naturally occurring genetic variants that confer beneficial effects on health and disease. The company has exceptional expertise in siRNA medicines and strives to create a new generation of precision medicines for common diseases with unmet needs. Collaborating with top-tier partners, Empirico's pipeline includes differentiated clinical and preclinical programs driven by a dedicated team of professionals in biology, chemistry, data science, and drug development.